The Steering Committee
The day-to-day management, as well as the representation of the EBF as far as the day-to-day management and external representation is concerned is delegated from the Board of Directors to a Steering Committee (SC) elected amongst the Pharma members.
The SC currently consists of the following 4 people :
- Philip Timmerman, Belgium, Chairman of the EBF
- Stephen White, GlaxoSmithKline, United Kingdom
- Tobias Haslberger, AbbVie, Germany
- Joanne Goodman, AstraZeneca, United Kingdom